Clinical Trials
Ceapro Inc. Receives Approval from Health Canada to Commence Phase 1/2a Human Clinical Trial Assessing Avenanthramide Tablets
Ceapro Inc., a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced it has received...
News
KangaBio and Aton Biotech Enter Into Development and Manufacturing Strategic Collaboration
Aton Biotech, a CDMO committed to enabling new biological drugs for clients with an integrated bio-pharmaceutical platform, and KangaBio have announced a strategic collaboration.
Both...
Drug Research
Lilly and ProQR to Expand RNA Editing Collaboration
Eli Lilly and Company and ProQR Therapeutics N.V. announced the expansion of their licensing and collaboration agreement focused on the discovery, development and commercialization...
Drug Research
Berkshire Sterile Manufacturing Expands Testing & Development Capabilities
Berkshire Sterile Manufacturing (BSM), a Massachusetts-based fill finish CDMO, recently purchased and validated three new analytical instruments to expand its testing and development capabilities.
While...
Drug Research
Micro-Sphere Launches R&D Lab in Switzerland
Global contract development and manufacturing organization Micro-Sphere has launched a new, 200 square-foot research and development (R&D) lab to strengthen its services in formulation...
Drug Research
Asymchem Opens New R&D Site Near Boston
Asymchem Laboratories (Tianjin) Co. Ltd., a CDMO serving the global pharmaceutical and biotech industry, has opened a new site in Woburn, Massachusetts.
Asymchem Boston, a...
Drug Research
Stem Cell Transplant May Halt The Onset of MS Disability
An Italian study that was recently published in Neurology, the official journal of the American Academy of Neurology, suggests that hematopoietic stem cell transplants...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read